Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USH1 protein network component sans (USH1G) is a scaffold protein containing multiple protein-binding domains, including ankyrin repeats and a sterile alpha motif (SAM) domain, which allow it to mediate the assembly of multi-protein complexes essential for inner ear hair cell and retinal photoreceptor function[3][5]. It forms a critical part of the Usher syndrome protein network, physically linking and stabilizing other USH1 proteins (such as harmonin/USH1C, cadherin 23, and myosin VIIa) that are necessary for mechanosensory transduction in hair cells and photoreceptors in the retina[1][3]. Recent findings show USH1G/SANS also regulates pre-mRNA splicing by mediating the intra-nuclear transfer and recycling of spliceosomal components, indicating a nuclear function besides its defined role in ciliary structures[3]. Mutations in USH1G cause Usher syndrome type 1G, the most severe form of hereditary deaf-blindness, due to progressive degeneration of auditory and visual sensory cells[1][3][5]. No therapeutic drugs are known to selectively target USH1G, and it is primarily studied as a disease gene/protein rather than as a tractable pharmacological target[3]. Key structural features: - N-terminal ankyrin repeats - Central (CENT) domain with numerous binding partners - C-terminal SAM domain and a PDZ-binding motif for scaffold activity[5] USH1G does not belong to classic receptor, enzyme, transporter, ion channel, or transcription factor families, but is classified as a scaffold/adaptor protein essential for the cell biology of specialized sensory cells[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on USH1 protein network component sans (USH1G).